메뉴 건너뛰기




Volumn 20, Issue 6, 2007, Pages 559-563

Initial experience with alcohol septal ablation using a novel magnetic navigation system

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL SEPTAL ABLATION; ARTICLE; CONTROLLED STUDY; GUIDE WIRE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAGNETICALLY ASSISTED INTERVENTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 36549003554     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2007.00285.x     Document Type: Article
Times cited : (6)

References (26)
  • 1
    • 0029043605 scopus 로고
    • Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
    • Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995 346 : 211 214.
    • (1995) Lancet , vol.346 , pp. 211-214
    • Sigwart, U.1
  • 2
    • 0037168004 scopus 로고    scopus 로고
    • Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy
    • Shamim W, Yousufuddin M, Wang D, et al. Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy. N Engl J Med 2002 347 : 1326 1333.
    • (2002) N Engl J Med , vol.347 , pp. 1326-1333
    • Shamim, W.1    Yousufuddin, M.2    Wang, D.3
  • 3
    • 0030997143 scopus 로고    scopus 로고
    • Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients
    • Knight C, Kurbaan AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients. Circulation 1997 95 : 2075 2081.
    • (1997) Circulation , vol.95 , pp. 2075-2081
    • Knight, C.1    Kurbaan, A.S.2    Seggewiss, H.3
  • 4
    • 14944368967 scopus 로고    scopus 로고
    • A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy-the Baylor experience (1996-2002)
    • Fernandes VL, Nagueh SF, Wang W, et al. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy-the Baylor experience (1996-2002). Clin Cardiol 2005 28 : 124 130.
    • (2005) Clin Cardiol , vol.28 , pp. 124-130
    • Fernandes, V.L.1    Nagueh, S.F.2    Wang, W.3
  • 5
    • 0031976561 scopus 로고    scopus 로고
    • Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients
    • Seggewiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998 31 : 252 258.
    • (1998) J Am Coll Cardiol , vol.31 , pp. 252-258
    • Seggewiss, H.1    Gleichmann, U.2    Faber, L.3
  • 6
    • 0042821502 scopus 로고    scopus 로고
    • Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy
    • Tsuchikane E, Takeda Y, Kobayashi T, et al. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Circ J 2003 67 : 763 767.
    • (2003) Circ J , vol.67 , pp. 763-767
    • Tsuchikane, E.1    Takeda, Y.2    Kobayashi, T.3
  • 7
    • 23744499778 scopus 로고    scopus 로고
    • Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: Follow-up results of the TASH-registry of the German Cardiac Society
    • Faber L, Seggewiss H, Gietzen FH, et al. Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: Follow-up results of the TASH-registry of the German Cardiac Society. Z Kardiol 2005 94 : 516 523.
    • (2005) Z Kardiol , vol.94 , pp. 516-523
    • Faber, L.1    Seggewiss, H.2    Gietzen, F.H.3
  • 8
    • 0042915870 scopus 로고    scopus 로고
    • Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: Early and intermediate results of a Canadian referral centre
    • Bhagwandeen R, Woo A, Ross J, et al. Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: Early and intermediate results of a Canadian referral centre. Can J Cardiol 2003 19 : 912 917.
    • (2003) Can J Cardiol , vol.19 , pp. 912-917
    • Bhagwandeen, R.1    Woo, A.2    Ross, J.3
  • 9
    • 3242809100 scopus 로고    scopus 로고
    • Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients
    • Guo H, Wang J, Chen J, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients. Can J Cardiol 2004 20 : 779 782.
    • (2004) Can J Cardiol , vol.20 , pp. 779-782
    • Guo, H.1    Wang, J.2    Chen, J.3
  • 10
    • 0347407808 scopus 로고    scopus 로고
    • Hypertrophic obstructive cardiomyopathy: Mechanism of obstruction and response to therapy
    • Yoerger DM, Weyman AE. Hypertrophic obstructive cardiomyopathy: Mechanism of obstruction and response to therapy. Rev Cardiovasc Med 2003 4 : 199 215.
    • (2003) Rev Cardiovasc Med , vol.4 , pp. 199-215
    • Yoerger, D.M.1    Weyman, A.E.2
  • 11
    • 0037378114 scopus 로고    scopus 로고
    • Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy
    • Sitges M, Shiota T, Lever HM, et al. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy. Am J Cardiol 2003 91 : 817 821.
    • (2003) Am J Cardiol , vol.91 , pp. 817-821
    • Sitges, M.1    Shiota, T.2    Lever, H.M.3
  • 12
    • 33746876319 scopus 로고    scopus 로고
    • Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A systematic review of published studies
    • Alam M, Dokainish H, Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A systematic review of published studies. J Interv Cardiol 2006 19 : 319 327.
    • (2006) J Interv Cardiol , vol.19 , pp. 319-327
    • Alam, M.1    Dokainish, H.2    Lakkis, N.3
  • 13
    • 0035890036 scopus 로고    scopus 로고
    • Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy
    • Nagueh SF, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001 38 : 1701 1706.
    • (2001) J Am Coll Cardiol , vol.38 , pp. 1701-1706
    • Nagueh, S.F.1    Ommen, S.R.2    Lakkis, N.M.3
  • 14
    • 0035199821 scopus 로고    scopus 로고
    • Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery
    • Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001 38 : 1994 2000.
    • (2001) J Am Coll Cardiol , vol.38 , pp. 1994-2000
    • Qin, J.X.1    Shiota, T.2    Lever, H.M.3
  • 15
    • 0029043605 scopus 로고
    • Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
    • Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995 346 : 211 214.
    • (1995) Lancet , vol.346 , pp. 211-214
    • Sigwart, U.1
  • 16
    • 21744450190 scopus 로고    scopus 로고
    • Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    • Abbas AE, Brewington SD, Dixon SR, et al. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. J Interv Cardiol 2005 18 : 155 162.
    • (2005) J Interv Cardiol , vol.18 , pp. 155-162
    • Abbas, A.E.1    Brewington, S.D.2    Dixon, S.R.3
  • 17
    • 0034908091 scopus 로고    scopus 로고
    • Anatomy of the first septal perforating artery: A study with implications for ablation therapy for hypertrophic cardiomyopathy
    • Singh M, Edwards WD, Holmes DR Jr., et al. Anatomy of the first septal perforating artery: A study with implications for ablation therapy for hypertrophic cardiomyopathy. Mayo Clin Proc 2001 76 : 799 802.
    • (2001) Mayo Clin Proc , vol.76 , pp. 799-802
    • Singh, M.1    Edwards, W.D.2    Holmes Jr., D.R.3
  • 18
    • 33747118391 scopus 로고    scopus 로고
    • Use of magnetic navigation to facilitate transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    • Bach RG, Leach C, Milov SA, et al. Use of magnetic navigation to facilitate transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy. J Invasive Cardiol 2006 18 : E176 E178.
    • (2006) J Invasive Cardiol , vol.18
    • Bach, R.G.1    Leach, C.2    Milov, S.A.3
  • 19
    • 31644448411 scopus 로고    scopus 로고
    • Initial experience with a magnetic navigation system for percutaneous coronary intervention in complex coronary artery lesions
    • Atmakuri SR, Lev EI, Alviar C, et al. Initial experience with a magnetic navigation system for percutaneous coronary intervention in complex coronary artery lesions. J Am Coll Cardiol 2006 47 : 515 521.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 515-521
    • Atmakuri, S.R.1    Lev, E.I.2    Alviar, C.3
  • 20
    • 33644764768 scopus 로고    scopus 로고
    • Guidewire navigation in coronary artery stenoses using a novel magnetic navigation system: First clinical experience
    • Tsuchida K, Garcia-Garcia HM, Van der Giessen WJ, et al. Guidewire navigation in coronary artery stenoses using a novel magnetic navigation system: First clinical experience. Catheter Cardiovasc Interv 2006 67 : 356 363.
    • (2006) Catheter Cardiovasc Interv , vol.67 , pp. 356-363
    • Tsuchida, K.1    Garcia-Garcia, H.M.2    Van Der Giessen, W.J.3
  • 21
    • 0029043605 scopus 로고
    • Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
    • Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995 346 : 211 214.
    • (1995) Lancet , vol.346 , pp. 211-214
    • Sigwart, U.1
  • 22
    • 21744450190 scopus 로고    scopus 로고
    • Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    • Abbas AE, Brewington SD, Dixon SR, et al. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. J Interv Cardiol 2005 18 : 155 162.
    • (2005) J Interv Cardiol , vol.18 , pp. 155-162
    • Abbas, A.E.1    Brewington, S.D.2    Dixon, S.R.3
  • 23
    • 0034908091 scopus 로고    scopus 로고
    • Anatomy of the first septal perforating artery: A study with implications for ablation therapy for hypertrophic cardiomyopathy
    • Singh M, Edwards WD, Holmes DR Jr., et al. Anatomy of the first septal perforating artery: A study with implications for ablation therapy for hypertrophic cardiomyopathy. Mayo Clin Proc 2001 76 : 799 802.
    • (2001) Mayo Clin Proc , vol.76 , pp. 799-802
    • Singh, M.1    Edwards, W.D.2    Holmes Jr., D.R.3
  • 24
    • 33747118391 scopus 로고    scopus 로고
    • Use of magnetic navigation to facilitate transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    • Bach RG, Leach C, Milov SA, et al. Use of magnetic navigation to facilitate transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy. J Invasive Cardiol 2006 18 : E176 E178.
    • (2006) J Invasive Cardiol , vol.18
    • Bach, R.G.1    Leach, C.2    Milov, S.A.3
  • 25
    • 4444319206 scopus 로고    scopus 로고
    • Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience
    • Faber L, Seggewiss H, Welge D, et al. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience. Euro J Echocardiogr 2004 5 : 347 355.
    • (2004) Euro J Echocardiogr , vol.5 , pp. 347-355
    • Faber, L.1    Seggewiss, H.2    Welge, D.3
  • 26
    • 33747118391 scopus 로고    scopus 로고
    • Use of magnetic navigation to facilitate transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    • Bach RG, Leach C, Milov SA, et al. Use of magnetic navigation to facilitate transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy. J Invasive Cardiol 2006 18 : E176 E178.
    • (2006) J Invasive Cardiol , vol.18
    • Bach, R.G.1    Leach, C.2    Milov, S.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.